Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07186842
Recruiting
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Phase 1/2 · Australia, Germany, Spain, United Kingdom, United States · 18 sites
Registry update: 15 Oct 2026
NCT07344844
Recruiting
Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer
Not applicable · Réunion · 1 site
Registry update: 15 Jan 2026
NCT07235371
Recruiting
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Not applicable · China · 1 site
Registry update: 6 Feb 2026
NCT07260175
Recruiting
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
Phase 2 · Germany · 20 sites
Registry update: 12 Aug 2026
NCT07243171
Recruiting
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Phase 1/2 · China · 1 site
Registry update: 16 Sept 2026
NCT07221344
Recruiting
Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease
Phase 1/2 · Canada, New Zealand · 4 sites
Registry update: 18 Sept 2026
NCT07351032
Recruiting
Understanding How Movements Are Transferred From Task to Task in Parkinson's Disease
Not applicable · Canada · 1 site
Registry update: 20 Jan 2026
NCT07192055
Recruiting
Self-sampling to Optimize Anal Lesion Outcomes
Not applicable · United States · 3 sites
Registry update: 12 May 2026
NCT07209098
Recruiting
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure
Not applicable · United States · 1 site
Registry update: 24 Mar 2026
NCT06948448
Recruiting
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Phase 2 · Canada, Spain, France, Italy, Japan, United States · 39 sites
Registry update: 16 Jul 2026
NCT07838740
Recruiting
A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities
Phase 1 · United States · 2 sites
Registry update: 24 Sept 2026
NCT07256704
Recruiting
Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)
Not applicable · Switzerland · 1 site
Registry update: 14 Aug 2026
2023-508547-51-00
Recruiting
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of rhinitis/rhinoconjunctivitis in patients allergic to house dust mites.
Phase 3 · Spain, Portugal · 17 sites
Registry update: 2 Jul 2026
NCT07253493
Recruiting
Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship
Not applicable · 1 site
Registry update: 28 Nov 2025
NCT07228832
Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Belgium, Canada, China, Czechia, Germany, Spain, France, United Kingdom, Hungary, Italy, Japan, Mexico, Poland, Puerto Rico, United States · 207 sites
Registry update: 5 Nov 2026
NCT07233720
Recruiting
Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone Lymphoma
Not applicable · China · 1 site
Registry update: 18 Nov 2025
NCT07363460
Recruiting
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
Phase 2 · China · 1 site
Registry update: 23 Jan 2026
NCT07182565
Recruiting
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
Phase 1/2 · China · 4 sites
Registry update: 6 Jan 2026
NCT07228468
Recruiting
Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
Not applicable · United Kingdom · 6 sites
Registry update: 26 Jan 2026
NCT06721949
Recruiting
Taurine Supplementation in Long COVID
Phase 2/3 · Canada · 5 sites
Registry update: 18 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.